Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen

被引:1
|
作者
Isha, Shahin [1 ]
Olaizola, Gustavo [2 ,3 ]
Bisso, Indalecio Carboni [2 ]
Raavi, Lekhya [1 ]
Jonna, Sadhana [1 ]
Jenkins, Anna [1 ]
Hanson, Abby [1 ]
Kashyap, Rahul [1 ,4 ]
Monzon, Veronica [5 ]
Huespe, Ivan A. [2 ,3 ]
Sanghavi, Devang [1 ]
机构
[1] Mayo Clin, Jacksonville, FL USA
[2] Hosp Italiano Buenos Aires, Buenos Aires, Argentina
[3] Univ Buenos Aires, Buenos Aires, Argentina
[4] Well Span Hlth, York, PA USA
[5] Hosp Italiano Agustin Roca, Buenos Aires, Argentina
关键词
ARDS; coronavirus disease 2019; high-flow nasal cannula oxygen; oxygen saturation; critical care; RESPIRATORY-DISTRESS-SYNDROME;
D O I
10.4187/respcare.11933
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> among non-intubated subjects with ARDS. Methods: This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 315 [with S<INF>pO<INF>2</INF></INF> <= 97%] or a P<INF>aO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 300 mm Hg while receiving >= 30 L/min O<INF>2</INF> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> cutoff proposed in the new ARDS definition, and mortality. Results: Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (n = 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (n = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (n = 98). Additionally, the worst S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (n = 177) for subjects with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 148, 17% (95% CI 12-23) (n = 38) for those with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> between 149-234, and 16% (95% CI 8-28) (n = 10) for subjects maintaining an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> higher than 235 (P < .001). Conclusions: The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [41] High-Flow Nasal Cannula and COVID-19: A Clinical Review
    Crimi, Claudia
    Pierucci, Paola
    Renda, Teresa
    Pisani, Lara
    Carlucci, Annalisa
    RESPIRATORY CARE, 2022, 67 (02) : 227 - 240
  • [42] INHALED EPOPROSTENOL WITH HIGH-FLOW NASAL CANNULA IN COVID ARDS
    Garg, Natasha
    Mahmoud, Omar
    Robin, Edith
    Shah, Dishant
    Zipf, Elizabeth
    Riego, Maria
    Salonia, James
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 139 - 139
  • [43] Spontaneous Pneumothorax in COVID-19 Patients Treated with High-Flow Nasal Cannula outside the ICU: A Case Series
    Nalewajska, Magdalena
    Feret, Wiktoria
    Wojczynski, Lukasz
    Witkiewicz, Wojciech
    Wisniewska, Magda
    Kotfis, Katarzyna
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (04) : 1 - 11
  • [44] Safety and Outcome of High-Flow Nasal Oxygen Therapy Outside ICU Setting in Hypoxemic Patients With COVID-19
    Janssen, Matthijs L.
    Turk, Yasemin
    Baart, Sara J.
    Hanselaar, Wessel
    Aga, Yaar
    van der Steen-Dieperink, Marielle
    van der Wal, Folkert J.
    Versluijs, Vera J.
    Hoek, Rogier A. S.
    Endeman, Henrik
    Boer, Dirk P.
    Hoiting, Oscar
    Hoelters, Jurgen
    Achterberg, Sefanja
    Stads, Susanne
    Heller-Baan, Roxane
    Dubois, Alain V. F.
    Elderman, Jan H.
    Wils, Evert-Jan
    CRITICAL CARE MEDICINE, 2024, 52 (01) : E31 - 43
  • [45] High-flow nasal oxygen in individuals with COVID-19 pneumonia and mild hypoxaemia: An independent discussion
    Einav, S.
    Ambrosino, N.
    PULMONOLOGY, 2022, 28 (06): : 423 - 426
  • [46] Use of high-flow nasal oxygen for pregnant women with COVID-19 in the labour ward setting
    Smith, J.
    Plaat, F.
    INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2023, 56
  • [47] Evaluating the use of the respiratory rate-oxygenation index as a predictor of high-flow nasal cannula oxygen failure in COVID-19
    Weerasuriya, Scott
    Vlachos, Savvas
    Bobo, Ahmed
    Jayaprabhu, Namitha Birur
    Matthews, Lauren
    Blackstock, Adam R.
    Metaxa, Victoria
    ACUTE AND CRITICAL CARE, 2023, 38 (01) : 31 - 40
  • [48] High-flow nasal cannula oxygen therapy: preliminary study in hospitalized patients
    Demelo-Rodriguez, Pablo
    Olmedo Samperio, Maria
    Gaitan Tocora, Daniel German
    Cano Ballesteros, Juan Carlos
    Andueza Lillo, Juan Antonio
    ARCHIVOS DE BRONCONEUMOLOGIA, 2015, 51 (12): : 657 - 659
  • [49] Outcomes and characteristics of COVID-19 patients treated with continuous positive airway pressure/high-flow nasal oxygen outside the intensive care setting
    Sykes, Dominic L.
    Crooks, Michael G.
    Khaing Thu Thu
    Brown, Oliver, I
    Tyrer, Theodore J. P.
    Rennardson, Jodie
    Littlefield, Catherine
    Faruqi, Shoaib
    ERJ OPEN RESEARCH, 2021, 7 (04)
  • [50] High-flow nasal oxygen in patients with COVID-19-associated acute respiratory failure
    Ricard Mellado-Artigas
    Bruno L. Ferreyro
    Federico Angriman
    María Hernández-Sanz
    Egoitz Arruti
    Antoni Torres
    Jesús Villar
    Laurent Brochard
    Carlos Ferrando
    Critical Care, 25